Tempus AI (NASDAQ:TEM) Trading Up 6.5% – What’s Next?

26 Jan 2026, 18:24 by Doug Wharley · The Cerbat Gem

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) shares rose 6.5% during trading on Monday . The stock traded as high as $69.95 and last traded at $69.5460. Approximately 2,871,974 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 5,625,994 shares. The stock had previously closed at $65.32.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on TEM. HC Wainwright dropped their price target on Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Morgan Stanley increased their target price on shares of Tempus AI from $80.00 to $85.00 and gave the stock an “overweight” rating in a report on Monday, December 1st. Canaccord Genuity Group reduced their price target on shares of Tempus AI from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Monday, December 22nd. Piper Sandler lowered their price objective on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Tempus AI from $85.00 to $80.00 and set a “neutral” rating on the stock in a research note on Monday, December 15th. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $87.20.

Get Our Latest Report on Tempus AI

Tempus AI Trading Up 3.5%

The firm’s 50-day simple moving average is $68.87 and its 200 day simple moving average is $73.89. The stock has a market cap of $12.03 billion, a P/E ratio of -56.83 and a beta of 5.22. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45.

Tempus AI (NASDAQ:TEM – Get Free Report) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The business had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. During the same period in the previous year, the firm posted ($0.46) earnings per share. The business’s revenue was up 84.7% on a year-over-year basis. As a group, equities research analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $89.11, for a total value of $29,629,075.00. Following the completion of the transaction, the chief executive officer owned 9,074,532 shares in the company, valued at $808,631,546.52. This represents a 3.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Ryan Fukushima sold 10,099 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $65.54, for a total transaction of $661,888.46. Following the transaction, the chief operating officer directly owned 829,081 shares in the company, valued at approximately $54,337,968.74. The trade was a 1.20% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 932,832 shares of company stock worth $71,184,024. 26.27% of the stock is owned by company insiders.

Hedge Funds Weigh In On Tempus AI

Several large investors have recently made changes to their positions in TEM. Trivium Point Advisory LLC grew its stake in shares of Tempus AI by 21.8% in the 4th quarter. Trivium Point Advisory LLC now owns 53,940 shares of the company’s stock worth $3,185,000 after purchasing an additional 9,640 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Tempus AI by 4.0% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 105,314 shares of the company’s stock valued at $6,219,000 after purchasing an additional 4,038 shares during the last quarter. CWM LLC boosted its holdings in Tempus AI by 1.0% during the fourth quarter. CWM LLC now owns 194,191 shares of the company’s stock worth $11,467,000 after buying an additional 1,997 shares in the last quarter. Farther Finance Advisors LLC grew its position in Tempus AI by 3.5% in the fourth quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock worth $377,000 after buying an additional 219 shares during the last quarter. Finally, Legacy Bridge LLC grew its position in Tempus AI by 1.6% in the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock worth $733,000 after buying an additional 193 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

(Get Free Report)

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.